Skip to main content
Top
Literature
1.
go back to reference Notarangelo LD. Chapter Four — Combined immunodeficiencies with nonfunctional T lymphocytes. In: Alt FW, editor. Advances in immunology. Academic Press; 2014. p. 121–90. Notarangelo LD. Chapter Four — Combined immunodeficiencies with nonfunctional T lymphocytes. In: Alt FW, editor. Advances in immunology. Academic Press; 2014. p. 121–90.
2.
go back to reference Roussel L, Landekic M, Golizeh M, et al. Loss of human ICOSL results in combined immunodeficiency. J Exp Med. 2018;215(12):3151–64.CrossRef Roussel L, Landekic M, Golizeh M, et al. Loss of human ICOSL results in combined immunodeficiency. J Exp Med. 2018;215(12):3151–64.CrossRef
3.
go back to reference Willmann KL, Klaver S, Doğu F, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360.CrossRef Willmann KL, Klaver S, Doğu F, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360.CrossRef
4.
go back to reference Lownik JC, Luker AJ, Damle SR, et al. ADAM10-mediated ICOS ligand shedding on B cells is necessary for proper T cell ICOS regulation and T follicular helper responses. J Immunol. 2017;199(7):2305–15.CrossRef Lownik JC, Luker AJ, Damle SR, et al. ADAM10-mediated ICOS ligand shedding on B cells is necessary for proper T cell ICOS regulation and T follicular helper responses. J Immunol. 2017;199(7):2305–15.CrossRef
5.
go back to reference Roussel L, Vinh DC. ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency. Curr Opin Immunol. 2021;72:21–6.CrossRef Roussel L, Vinh DC. ICOSL in host defense at epithelial barriers: lessons from ICOSLG deficiency. Curr Opin Immunol. 2021;72:21–6.CrossRef
Metadata
Title
Late-Onset Combined Immunodeficiency with Refractory CMV Disease due to ICOSL Deficiency
Authors
Vivian G. Loo
Lucie Roussel
Stéphane Bernier
Anna Perez
Donald C. Vinh
Publication date
01-01-2022
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2022
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01162-9

Other articles of this Issue 1/2022

Journal of Clinical Immunology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.